Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Xenetic Biosciences, Inc.

NASDAQ: XBIO · Life Sciences · 4 alerts · CIK 1534525

Share price
$1.49Close, Nov 16
Market cap
$3.49M
Shares outstanding
2.34MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Xenetic Biosciences, Inc. filings on SEC EDGAR ↗

5:01 PM ET 10-Q
Financial Results

Xenetic Biosciences Q3 2026 Results: Net Loss of $1.7M, Loss Widens

Xenetic Biosciences reported a net loss of $3.1 million for the nine months ended September 30, 2026, compared to $2.1 million in the prior year period, driven primarily by a significant increase in general and administrative expenses. Total revenue, derived from royalties, remained relatively flat at $2.2 million for the nine-month period. The company ended the quarter with $5.8 million in cash and is focused on advancing its systemic DNase program into clinical trials.

Key figure
Net loss $1.7M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.